Thermo Fisher Scientific Bevacizumab Recombinant Rabbit Monoclonal Antibody (46E3), MonoRab
Recombinant rabbit monoclonal antibody (clone 46E3) targeting Bevacizumab. ELISA 검증 완료, 고순도 Protein A 정제. Lyophilized 형태로 안정적 보관 가능하며, VEGF-A 억제 연구에 적합. 연구용으로만 사용.
- 판매단위
- pk
카탈로그
1개 옵션 · 카탈로그 번호를 클릭하면 복사됩니다Thermo Fisher Scientific · Thermo Fisher Scientific Bevacizumab Recombinant Rabbit Monoclonal Antibody (46E3), MonoRab
Applications
ELISA
- Tested Dilution: 0.01–0.05 µg/mL
Product Specifications
| 항목 | 내용 |
|---|---|
| Species Reactivity | Human |
| Host / Isotype | Rabbit / IgG |
| Expression System | Mammalian cells |
| Class | Recombinant Monoclonal |
| Type | Antibody |
| Clone | 46E3 |
| Immunogen | Bevacizumab |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Purification | Protein A |
| Storage Buffer | PBS, pH 7.4 |
| Contains | 0.02% sodium azide |
| Storage Conditions | -20°C or -80°C if preferred |
| Shipping Conditions | Ambient (domestic); Wet ice (international) |
Additional Formats
Product Specific Information
Reconstitute the lyophilized antibody with deionized water (or equivalent) to a final concentration of 0.5 mg/mL.
Bevacizumab (Avastin) is a humanized monoclonal antibody approved by the U.S. FDA for treatment of colon cancer, lung cancer, glioblastoma, renal-cell carcinoma, and age-related macular degeneration.
Bevacizumab functions as an angiogenesis inhibitor by blocking vascular endothelial growth factor A (VEGF-A).
Target Information
Bevacizumab (Avastin) is a humanized monoclonal antibody approved by the U.S. FDA for treatment of colon cancer, lung cancer, glioblastoma, renal-cell carcinoma, and age-related macular degeneration.
As an angiogenesis inhibitor, Bevacizumab blocks angiogenesis by inhibiting vascular endothelial growth factor A (VEGF-A).
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Thermo Fisher Scientific 상품 둘러보기
전체보기
문의
0개 · 배송·재고 문의는 실시간 상담이 빠릅니다아직 등록된 문의가 없어요.